Suli Pharmaceutical Technology Jiangyin Co., Ltd. announced that it expects to receive CNY 40 million in funding from Suli Co., Ltd.
June 20, 2021
Share
Suli Pharmaceutical Technology Jiangyin Co., Ltd. announced that it will receive CNY 40,000,000 in equity round of funding on June 21, 2021. The transaction included participation from returning investor Suli Co., Ltd. (SHSE:603585) which will retain its 100% stake in the company after the transaction. The registered capital of the company will increase from CNY 50,000,000 to CNY 90,000,000. The transaction has been approved at the investor's 17th meeting of the 3rd directorate and does not need the shareholders’ approval.
Suli Co., Ltd. is a China-based company principally engaged in the research, development, manufacture and distribution of pesticides, flame retardants and other fine chemical products. Its pesticides include chlorothalonil, azoxystrobin, pesticide agent and other pesticide products. Its flame retardants products include decabromodiphenylethane, flame retardant masterbatch and other flame retardant products. Its other fine chemical products include hydrobromic acid and other products. The Company distributes its products within domestic market and to overseas markets.
SULI CO., LTD. 
